BACKGROUND: Enterochromaffin cells and enteric neurons synthesize and release serotonin (5-HT). Reuptake, mediated by a plasmalemmal transporter (SERT) terminates the action of released 5-HT. Serotonin secretion and serotonin reuptake transporter (SERT) expression have been reported to be decreased in TNBS-induced experimental colitis and in patients with ulcerative colitis. The present study was designed to utilize the transgenic deletion of SERT as a gain-of-function model to test the hypothesis that 5-HT is a pro-inflammatory mediator in experimental colitis. METHODS: Colitis was compared in animals with IL10(+/+)SERT(+/+) (wild-type), IL10(-/-)SERT(+/+), IL10(-/-)SERT(+/-), and IL10(-/-)/SERT(-/-) (double knockout) genotypes. Macroscopic and histological damage scores were evaluated after a time period of up to 15 weeks. KEY RESULTS: Serotonin reuptake transporter expression was significantly increased in the inflamed colons of IL-10(-/-) mice, which displayed intestinal damage and a minor decrement in general health. General health was significantly worse and intestinal inflammation was more severe in IL-10(-/-)SERT(+/-), and IL-10(-/-)SERT(-/-) mice than in IL-10(-/-)SERT(+/+) or wild-type animals. Regardless of the associated SERT genotype, the number of 5-HT-immunoreactive cells was decreased by approximately 55-65% in all mice lacking IL-10. CONCLUSIONS & INFERENCES: Our observations indicate that colitis associated with IL-10 deficient mice is enhanced when the IL-10 deficiency is combined with a SERT deficiency. The data support the concept that 5-HT is a pro-inflammatory mediator in the gut.
BACKGROUND: Enterochromaffin cells and enteric neurons synthesize and release serotonin (5-HT). Reuptake, mediated by a plasmalemmal transporter (SERT) terminates the action of released 5-HT. Serotonin secretion and serotonin reuptake transporter (SERT) expression have been reported to be decreased in TNBS-induced experimental colitis and in patients with ulcerative colitis. The present study was designed to utilize the transgenic deletion of SERT as a gain-of-function model to test the hypothesis that 5-HT is a pro-inflammatory mediator in experimental colitis. METHODS:Colitis was compared in animals with IL10(+/+)SERT(+/+) (wild-type), IL10(-/-)SERT(+/+), IL10(-/-)SERT(+/-), and IL10(-/-)/SERT(-/-) (double knockout) genotypes. Macroscopic and histological damage scores were evaluated after a time period of up to 15 weeks. KEY RESULTS:Serotonin reuptake transporter expression was significantly increased in the inflamed colons of IL-10(-/-) mice, which displayed intestinal damage and a minor decrement in general health. General health was significantly worse and intestinal inflammation was more severe in IL-10(-/-)SERT(+/-), and IL-10(-/-)SERT(-/-) mice than in IL-10(-/-)SERT(+/+) or wild-type animals. Regardless of the associated SERT genotype, the number of 5-HT-immunoreactive cells was decreased by approximately 55-65% in all mice lacking IL-10. CONCLUSIONS & INFERENCES: Our observations indicate that colitis associated with IL-10 deficient mice is enhanced when the IL-10 deficiency is combined with a SERT deficiency. The data support the concept that 5-HT is a pro-inflammatory mediator in the gut.
Authors: David R Linden; Jing-Xian Chen; Michael D Gershon; Keith A Sharkey; Gary M Mawe Journal: Am J Physiol Gastrointest Liver Physiol Date: 2003-03-19 Impact factor: 4.052
Authors: Jennifer R O'Hara; Winnie Ho; David R Linden; Gary M Mawe; Keith A Sharkey Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-07-01 Impact factor: 4.052
Authors: Matthew D Coates; Christine R Mahoney; David R Linden; Joanna E Sampson; Jason Chen; Hagen Blaszyk; Michael D Crowell; Keith A Sharkey; Michael D Gershon; Gary M Mawe; Peter L Moses Journal: Gastroenterology Date: 2004-06 Impact factor: 22.682
Authors: Marco Idzko; Elisabeth Panther; Christian Stratz; Tobias Müller; Hannes Bayer; Gernot Zissel; Thorsten Dürk; Stephan Sorichter; Francesco Di Virgilio; Michael Geissler; Bernd Fiebich; Yared Herouy; Peter Elsner; Johannes Norgauer; Davide Ferrari Journal: J Immunol Date: 2004-05-15 Impact factor: 5.422
Authors: Kara Gross Margolis; Jennifer Vittorio; Maria Talavera; Karen Gluck; Zhishan Li; Alina Iuga; Korey Stevanovic; Virginia Saurman; Narek Israelyan; Martha G Welch; Michael D Gershon Journal: Am J Physiol Gastrointest Liver Physiol Date: 2017-08-03 Impact factor: 4.052
Authors: Kara Gross Margolis; Korey Stevanovic; Nima Karamooz; Zi Shan Li; Ankur Ahuja; Fabien D'Autréaux; Virginia Saurman; Alcmene Chalazonitis; Michael David Gershon Journal: Gastroenterology Date: 2011-04-28 Impact factor: 22.682
Authors: Ravinarayan Raghupathi; Michael D Duffield; Leah Zelkas; Adrian Meedeniya; Simon J H Brookes; Tiong Cheng Sia; David A Wattchow; Nick J Spencer; Damien J Keating Journal: J Physiol Date: 2013-10-07 Impact factor: 5.182